These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31165076)

  • 1.
    Zullo A; Perrotta G; D'Angelo R; Ruggiero L; Gravino E; Del Vecchio L; Santoro L; Salvatore F; Carsana A
    Biomed Res Int; 2019; 2019():7638946. PubMed ID: 31165076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy.
    Kraeva N; Heytens L; Jungbluth H; Treves S; Voermans N; Kamsteeg E; Ceuterick-de Groote C; Baets J; Riazi S
    Neuromuscul Disord; 2015 Jul; 25(7):567-76. PubMed ID: 25958340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia.
    Parker R; Schiemann AH; Langton E; Bulger T; Pollock N; Bjorksten A; Gillies R; Hutchinson D; Roxburgh R; Stowell KM
    J Neuromuscul Dis; 2017; 4(2):147-158. PubMed ID: 28527222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia.
    Schiemann AH; Roesl C; Pollock N; Langton E; Bulger T; Stowell KM
    J Neuromuscul Dis; 2020; 7(1):51-60. PubMed ID: 31903994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
    Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
    Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
    Avila G; Dirksen RT
    J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.
    Treves S; Jungbluth H; Muntoni F; Zorzato F
    Curr Opin Pharmacol; 2008 Jun; 8(3):319-26. PubMed ID: 18313359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility.
    Taylor A; Lachlan K; Manners RM; Lotery AJ
    J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
    Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
    Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms.
    Lyfenko AD; Ducreux S; Wang Y; Xu L; Zorzato F; Ferreiro A; Meissner G; Treves S; Dirksen RT
    Hum Mutat; 2007 Jan; 28(1):61-8. PubMed ID: 16958053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Landrieu P; Nivoche Y; Fardeau M; Lunardi J
    Hum Mol Genet; 2001 Oct; 10(22):2581-92. PubMed ID: 11709545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Lillis S; Zhou H; Abbs S; Sewry C; Swash M; Muntoni F
    Neuromuscul Disord; 2009 May; 19(5):344-7. PubMed ID: 19303294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex].
    Lunardi J; Monnier N
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S70-7. PubMed ID: 15269663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies.
    Zhou H; Brockington M; Jungbluth H; Monk D; Stanier P; Sewry CA; Moore GE; Muntoni F
    Am J Hum Genet; 2006 Nov; 79(5):859-68. PubMed ID: 17033962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
    Tilgen N; Zorzato F; Halliger-Keller B; Muntoni F; Sewry C; Palmucci LM; Schneider C; Hauser E; Lehmann-Horn F; Müller CR; Treves S
    Hum Mol Genet; 2001 Dec; 10(25):2879-87. PubMed ID: 11741831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.